[1]. Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Brain : a journal of neurology [巻]145 [号]2 [頁]490 -499 （2022年）
[DOI] [2]. Extrastriatal dopamine D2/3 receptor binding, functional connectivity, and autism socio-communicational deficits: a PET and fMRI study.
Molecular psychiatry （2022年） [査読] 有
[DOI] [機関リポジトリ][3]. Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.
Psychiatry research [巻]301 [頁]113967 （2021年）
[DOI] [4]. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
Molecular autism [巻]12 [号]1 [頁]15 （2021年）
[DOI] [5]. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
Journal of psychiatric research [巻]134 [頁]48 -56 （2021年）
[DOI] [6]. Individual psychotherapy using psychological first aid for frontline nurses at high risk of psychological distress during the COVID-19 pandemic.
Psychiatry and clinical neurosciences [巻]75 [号]1 [頁]25 -27 （2021年） [査読] 有
[DOI] [7]. Neural correlates of head restraint: Unsolicited neuronal activation and dopamine release.
NeuroImage [巻]224 [頁]117434 （2021年）
[DOI] [8]. Simultaneous evaluation of antioxidative serum profiles facilitates the diagnostic screening of autism spectrum disorder in under-6-year-old children.
Scientific reports [巻]10 [号]1 [頁]20602 （2020年）
[DOI] [9]. VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction.
EBioMedicine [巻]58 [頁]102917 （2020年）
[DOI] [10]. うつ病に対する経頭蓋直流電気刺激法：有効性と安全性
〈講座 精神疾患の臨床〉「気分障害(気分症)」 中山書店 （2019年） [査読] 有